| A. Menarini GmbH - Ranexa 500 mg, Retardtabletten | | 60533 | | 02 | | Ranexa 500 mg | | Retardtabletten | | C01EB18 | | Ranolazine | | 13.04.2010 | | |
| | Composition | | ranolazinum 500 mg, cellulosum microcristallinum, acidi methacrylici et methylis methacrylatis polymerisatum 1:1, hypromellosum, magnesii stearas, natrii hydroxidum corresp. natrium 1.54 mg, Überzug: macrogolum 3350, poly(alcohol vinylicus), talcum, cera carnauba, E 171, E 172 (flavum), E 172 (rubrum), pro compresso obducto. | | Packungsbestandteile | | Comprimés retards | | | | | Principe actif | Concentr. |
|---|
| Ranolazinum | 500 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Ranolazinum | 500 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| (Flavum) | | | | (Rubrum) | | | | Acidi Methacrylici | | | | Cellulosum Microcristallinum | | | | Cera Carnauba | | | | E 171 | | color. | | E 172 | | color. | | Hypromellosum | | | | Macrogol | 3350 | Überzug | | Magnesii Stearas | | | | Methylis Methacrylatis Polymerisatum | | | | Sodium Hydroxide | | | | Poly(Alcohol Vinylicus) | | | | Pro Compresso Obducto | | | | Talcum | | |
| |
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 004 | 30 Comprimé(s) | | | B | | Oui | | 005 | 60 Comprimé(s) | 46.31 | 66.80 | B | LS | Non | | 006 | 100 Comprimé(s) | 75.73 | 98.80 | B | LS | Non |
|
|
